Newsroom

For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org​​​​​​​ or 202-536-2285.

• STATEMENT ON 22ND DRUG COMPANY REFUSING TO OFFER 340B DRUG PRICING; NOVO NORDISK FURTHER RESTRICTS 340B CONTRACT PHARMACY PRICING

  June 02, 2023 in 340B Health News Releases

• STATEMENT ON COMMITTEE PASSAGE OF HARMFUL HOUSE 340B LEGISLATION

  May 24, 2023 in 340B Health News Releases

• JOINT STATEMENT FROM NATIONAL HOSPITAL AND PHARMACIST ASSOCIATIONS ON HARMFUL HOUSE 340B LEGISLATION

  May 23, 2023 in 340B Health News Releases

• STATEMENT ON HOUSE SUBCOMMITTEE APPROVAL OF 340B REPORTING MANDATE

  May 17, 2023 in 340B Health News Releases

• AHA, 340B HEALTH, ARKANSAS HOSPITAL ASSOCIATION URGE FEDERAL APPEALS COURT TO UPHOLD STATE LAW PROTECTING 340B COMMUNITY PHARMACIES

  April 17, 2023 in 340B Health News Releases

• 340B HEALTH ADDS VETERAN COMMUNICATIONS LEADER TO TEAM

  April 17, 2023 in 340B Health News Releases

• STATEMENT ON THE BIPARTISAN PROTECT 340B ACT TO BAN DISCRIMINATORY PAYMENT POLICIES

  April 06, 2023 in 340B Health News Releases

• REPORT: DRUG COMPANIES STRIPPING BILLIONS OF DOLLARS FROM HEALTH CARE SAFETY NET TO AVOID 340B PENALTIES AND SPECIALTY DRUG DISCOUNTS

  March 23, 2023 in 340B Health News Releases

• JOINT STATEMENT FROM NATIONAL HOSPITAL AND PHARMACIST ASSOCIATIONS ON PHRMA-LED PROPOSAL TO RESTRICT 340B ELIGIBILITY

  March 20, 2023 in 340B Health News Releases

• STATEMENT ON PHRMA AND NACHC PROPOSAL TO REDUCE SAFETY-NET HOSPITAL PARTICIPATION IN 340B

  March 09, 2023 in 340B Health News Releases

• STATEMENT ON NEW JOHNSON & JOHNSON RESTRICTIONS ON 340B ACCESS

  February 22, 2023 in 340B Health News Releases

• UPDATED: STATEMENT ON BAYER AND EMD SERONO RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  February 01, 2023 in 340B Health News Releases